Available Until 12/31/2022

New mAbs on the Block: A Rocking Research Update on Biosimilar Uptake and Benefit Design Strategies in the United States

Course Description:

Despite 20 biosimilar launches and almost 30 approvals in the United States, there are still challenges to biosimilar adoption among a variety of stakeholders across the health care continuum. The regulatory environment is frequently a part of this biosimilar market discussion. Recent research surveying managed care and specialty pharmacy professionals provides insight to perceptions of barriers to biosimilar adoption and to identify preferences, policies, and strategies for biosimilar use across organizations. Is it time to rock with the new mAbs on the block?

During this session, faculty will provide an update on the biosimilar landscape from a pipeline and regulatory perspective, share key findings from their primary research, and provide a framework for leveraging biosimilars in utilization management and benefit design.

Learning Objectives:

At the completion of this activity, participants should be able to:
  1. Describe the therapeutic areas, pipeline, and regulatory environment affecting the biosimilar landscape in the United States.
  2. Report results of current research on barriers to biosimilar adoption and impact of benefit design and formulary policies on utilization.
  3. Discuss prospective payer management strategies in anticipation of market entry of pharmacy benefit biosimilars.


Faculty:

Tasmina Hydery, PharmD, MBA, BCGP

Assistant Director of Integrated Technology Solutions

AmerisourceBergen/Xcenda

Millbury, MA


Cate Lockhart, MS, PharmD, PhD

Executive Director

Biologics and Biosimilars Collective Intelligence Consortium

Alexandria, VA


Jennifer Snow, MPH

Vice President, Reimbursement and Policy Insights

AmerisourceBergen/Xcenda

Bethesda, MD


Moderator:

Craig Mattson, RPh, MS, MBA

President

Mattson Consulting

Plymouth, Minnesota


Accreditation:

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE UAN:0233-0000-21-044-H04-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: October 19, 2021 •  Expiration Date: December 31, 2022
Activity Fee: Free for Members and $30 for Non-Members

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP Nexus 2021. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.


System Technical Requirements/Viewing Requirements:

System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-21-044-H04-P 1.25 Contact Hours October 19, 2021 - December 31, 2022